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After the initial discovery of VPS13A as the causative gene of the neurodegenerative disease Chorea-
Acanthocytosis (ChAc) 17 years ago, research and knowledge about its function progressed very slowly. 
Desired progression in management and treatment of ChAc demands better understanding of the 
underlying disease mechanisms and affected cellular processes. Therefore we aimed to shed more light 
on VPS13A function and localization by focusing on a multicellular Drosophila disease model, as well as by 
studying mammalian cell models. 
The fruit fly as a model organism to study neurodegenerative diseases and Chorea-
Acanthocytosis in particular 
The investigation of human diseases is largely dependent on the use of model systems and organisms, 
including different cell lines for in vitro studies and in vivo models like yeast, fruit flies and mice. Drosophila 
melanogaster, or the fruit fly, proved to be of high importance in the study and understanding of many 
human diseases. Their maintenance is easy and relatively cheap, they can be produced in large numbers 
with an identical genetic background and the possibilities for genetic and pharmacological manipulation 
are extensive. Research using the versatility of the fruit fly has already contributed to knowledge about 
various neurodegenerative diseases, which we reviewed in Chapter 21. For our research we aimed to 
utilize the fruit fly to investigate Vps13, the Drosophila ortholog of VPS13A. Because most data available on 
VPS13A function has been acquired with the use of unicellular eukaryotic organisms like yeast and ciliates, 
the urgency for a multicellular model to investigate the function of VPS13A and the consequences of 
VPS13A depletion or absence is high. A mouse model for ChAc was developed, but the neurodegenerative 
phenotypes are variable and depend heavily on the genetic background of the mice strain in which the 
VPS13A mutation is generated2, further increasing the need for a solid multicellular model organism. 
To address this issue, we established and characterized a Drosophila melanogaster model for ChAc as 
described in Chapter 3 of this thesis. With the use of this Vps13 fly mutant we assessed the consequences 
of Vps13 dysfunction on the central nervous system and found that it is associated with a reduced life span 
and neurodegeneration3. We further demonstrated that Vps13 mutant flies are sensitive to proteotoxic 
stress and show impaired protein homeostasis, which leads to the accumulation of ubiquitinated proteins 
in the central nervous system of both larvae and adult flies. Rescue of some of these phenotypes by the 
overexpression of human VPS13A in the Vps13 mutant flies is suggestive of functional conservation of both 
human and Drosophila genes and proteins3. 
Protein synthesis, folding, trafficking and degradation are kept in tight balance and defects in protein 
homeostasis have been associated with several neurodegenerative diseases for quite some time now4,5. 
Aggregation of misfolded proteins is a hallmark of diseases like Alzheimer, Parkinson and Polyglutamine 
diseases, usually as a consequence of a gain-of-function mutation. Since ChAc is caused by homozygous 
loss-of-function mutations it seems improbable that absence of VPS13A directly and actively promotes 
protein aggregation, it is therefore more likely that VPS13A plays a role in  the elimination of misfolded 
or defective proteins through mechanisms like autophagy to maintain a stable and functional 
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proteome. Autophagy is a cellular degradation mechanism that disassembles unnecessary and defective 
cytoplasmic content. VPS13A has been implicated to play a role in the autophagic pathway7 and it was 
shown that autophagic flux and autolysosomal degradation is impaired in cells of ChAc patients8. Our 
co-fractionation experiments revealed that Vps13 is a peripheral membrane protein associated with Rab7 
positive membranes3. Rab7 is a GTPase associated with late endosomes and lysosomes known to play 
an important role in endosomal membrane trafficking and autophagosome formation9,10. Dysfunction 
of Rab7 leads to the accumulation of autophagosomes11. Interestingly, VPS13A-depleted human cells 
accumulate autophagosomal markers7. In addition, yeast VPS13 plays an important role in transport of 
membrane proteins to the vacuole, the yeast version of the lysosome12–14. Our data suggest localization 
and function of Vps13 in the autophagic degradative pathway, possibly in the transport or fusion of 
autophagic organelles and lysosomes. 
A role for Vps13 in apoptotic cell removal
In Chapter 5 we identified a cell-autonomous role for Vps13 during developmental programmed cell 
death (PCD) in the Drosophila ovary. The processes of cell death induction and the consecutive removal 
of the dying nurse cells (NCs) and their enormous nuclei are still poorly understood. Currently, most 
attention is paid to non-autonomous cell death induction during developmental PCD in late oogenesis, 
where surrounding follicle cells (FCs) promote the death of NCs. The phagocytic receptors Draper and 
Ced-12 were identified as crucial factors in this process, as well as the integrin subunit βPS315,16. It was 
suggested that Draper functions in a parallel pathway from integrins and Ced-12, where integrins probably 
act upstream of Ced-1216. Combined inhibition of both pathways failed to completely block NC removal16 
which suggests the presence of another pathway or redundant mechanism necessary for the complete 
removal of all NCs. Absence of Vps13 in the NCs specifically causes defects in the clearance of dying 
NCs, leading to the accumulation of persistent nurse cell nuclei (PNCN), while Vps13 depletion in the FCs 
did not lead to PNCN accumulation (Chapter 5). Using antibody staining and expression of endogenous 
Vps13-GFP we localized Vps13 in close proximity to the plasma membrane and the nuclear envelope of 
NCs in late oogenesis. The Vps13 signal surrounding NC nuclei was most intense when nuclei were not 
yet completely fragmented and degraded (Chapter 5). Furthermore we showed that acidification of the 
NC nuclei is not affected in Vps13 mutants, which suggests that Vps13 functions downstream of cell death 
induction by Draper and integrins, but is required for the proper removal of dying NCs. Co-localization 
studies of Vps13 with multiple organelle markers in late oogenesis did not show any overlap (unpublished 
data) pointing to a possible novel underlying Vps13-dependent structure. To investigate this structure, we 
performed electron microscopy of wild type and Vps13 mutant ovaries to identify structural differences 
as a consequence of the absence of Vps13, focusing on NC nuclei in late oogenesis that started but not 
yet completed the nuclear fragmentation. In ovaries of control flies we observed a special membrane 
adjacent to the plasma membrane that was absent in Vps13 mutants, suggesting that this Vps13-dependent 
membrane structure is involved in the proper removal of dying NCs in developmental PCD. 
Selective removal and degradation of portions of the nucleus is under specific conditions necessary to 
promote viability of a cell17,18. This degradation occurs via the process of nucleophagy19. It often requires 
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the core autophagy genes20 and is described in yeast21, filamentous fungi22 and the ciliate Tetrahymena 
thermophila23,24. Usually nucleophagy involves only damaged and non-essential nuclear components, 
including parts of the nuclear envelope and the granular nucleolus, and is mainly crucial to promote 
viability of a cell17,25. Encapsulation of nucleus-derived cargo by autophagosomes that later fuse with 
lysosomes leading to degradation is referred to as macronucleophagy26,27, while during micronucleophagy 
the nucleus is in direct contact with lysosomes or the yeast vacuole that engulf small portions of the 
nucleus20,21,28. Nuclear vacuole junctions (NVJ) in the yeast Saccharomyces cerevisiae are known to 
promote micronucleophagy using two key proteins Vac8 and Nvj117,29. Interestingly, in yeast VPS13 was 
found at NVJs30,31 and loss of VPS13 increases the length of individual NVJs, possibly to compensate for the 
lack of VPS13-containing NVJs31. Although the exact function of VPS13 at NVJs still has to be resolved, VPS13 
is currently thought to play a role in lipid transport at different membrane contact sites, including NVJs. 
In combination with our results in Drosophila it is tempting to speculate that VPS13 in yeast plays a role in 
nucleophagy at NVJs. More research is necessary to investigate this hypothesis.
Autophagy is involved in developmental PCD in the Drosophila ovary, although its role is only minor32,33. 
However, it has been shown that apoptotic vesicles containing nuclear material of dying NCs are engulfed 
by follicle cells33,34 suggestive for nucleophagy. The origin of the membranes that enclose the nuclear 
material is unknown and needs to be studied in further detail. Vps13 could be involved in the process of 
nucleophagy, both in micronucleophagy via its localization at the NVJs in lower eukaryotes, as well as in 
macronucleophagy where Vps13 supports the formation of specialized membranes that enclose parts of 
the nucleus that need to be degraded. Further studies are required for the investigation of a function for 
nucleophagy during developmental PCD in the Drosophila ovary and the involvement of Vps13 herein. 
We demonstrated a functional conservation of human VPS13A in the removal of dying NCs during late 
oogenesis, as overexpression of human VPS13A in the Vps13 mutant background significantly reduced the 
accumulation of PNCN (Chapter 5). Unfortunately we cannot conclude yet whether the removal of dying 
cells is generally affected in ChAc patients. It would therefore be very interesting to investigate whether 
removal of dying neurons for example is impaired in the Vps13 Drosophila mutant, which might provide 
a link to the neurodegeneration that characterizes ChAc. Interestingly, it was reported that erythrocytes 
of ChAc patients show reduced exposure of phosphatidylserine (PS) upon stimulation with LPA35. PS is a 
highly conserved phospholipid that is exposed on the surface of apoptotic cells and is recognized as a 
universal ‘eat-me’ signal36–38. Vps13 might play a role in the exposure of PS in dying NCs and thereby induce 
their removal. Absence of Vps13 would then cause a delay or deficiency in the proper removal of dying 
NCs. Involvement of PS exposure during developmental PCD has not been shown to date, but due to the 
universality of PS as an eat-me signal it is likely that PS plays a role in the removal of dying NC during late 
oogenesis as well. Unfortunately, detection of PS in ovaries suffers from technical difficulties as stainings 
with Annexin V, the reporter often used to visualize PS exposure, is unable to penetrate the FC layer to 
reach the dying NCs (preliminary results).  
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VPS13A function in membrane contact sites and lipid droplet homeostasis
We and others found that Vps13 is a peripheral membrane protein associated with different membrane 
structures depending on the organism3,13 (Chapter 6). In Chapter 6 we showed that human VPS13A is 
dynamically associated with the Endoplasmic Reticulum (ER) and mitochondria via different binding 
domains. Association with mitochondria is dependent on the C-terminus of VPS13A, although it is unclear 
whether this is a direct or indirect binding. Direct binding of VPS13A to the ER protein VAP-A is dependent 
on the FFAT motif present in VPS13A. Furthermore we showed that an increase in lipid content causes 
translocation of VPS13A from mitochondria to lipid droplets (LDs) (Chapter 6). Presence of VPS13A on 
many organelle membranes and at the interface between ER and mitochondria, its response to increased 
lipid content and regulation of lipid droplet (LD) mobility implicates a function in lipid homeostasis and 
membrane contact sites. 
Movement, transport and exchange of lipids is crucial to maintain the proper composition of the different 
organelles in a cell39. Communication and exchange of ions, lipids and other metabolites between 
organelles can occur through vesicular trafficking pathways and membrane contact sites (MCSs), which 
are defined as regions where two organelles come closely together (10-30 nm)39–41. In Saccharomyces 
cerevisiae, VPS13 was shown to bypass defects in the ER-mitochondria tethering complex ERMES through 
its localization at vacuole-mitochondria contact sites, while combined loss of ERMES and VPS13 is 
lethal30,42, suggestive for a crucial role for VPS13 in MCSs. VPS13 localization to different MCSs is dependent 
on nutritional status and growth conditions of the yeast30,31. Very recent work of Bean and colleagues 
(2018)43 characterized a binding motif that can be found in multiple VPS13-adaptor proteins, with slight 
differences depending on the protein. VPS13 localization to different membranes and MCSs is regulated 
through competition of those adaptor proteins that all bind to a conserved six-repeat region in VPS1343. 
The exact function of VPS13 at the different MCSs still remains elusive.
We provide evidence that mammalian VPS13A localizes at membrane contact sites and plays a role in 
lipid homeostasis (Chapter 6). Most ER MCSs are mediated by VAP proteins44 that bind other proteins 
containing an FFAT domain45. Time-lapse imaging reveals simultaneous overlap of VPS13A signal with 
both mitochondria and ER, and the binding of VPS13A to VAP-A is dependent on its FFAT motif since a 
VPS13A FFAT-deletion mutant no longer localizes to the mitochondria-ER interface but solely localizes to 
mitochondria (Chapter 6). Increased cytoplasmic calcium levels caused an increase in VPS13A and VAP-A 
binding, which suggests VPS13A involvement in ER-mitochondria contact sites, as it known that cellular 
calcium levels regulate the assembly of MCSs46,47.
Induction of intracellular LD formation by exogenous addition of oleic acid (OA) causes VPS13A to shift 
from ER to LDs where it uniformly encircles the individual LDs. Furthermore, presence of VPS13A on 
LDs causes a slowdown in their movement while downregulation of VPS13A causes an increase in both 
numbers and size of LDs. Interestingly, the Drosophila Vps13 mutant shows accumulation of LDs in glia 
cells of the central nervous system (Chapter 6). Together this strongly implies a role for VPS13A in LD 
homeostasis, which might as well apply to Drosophila Vps13 as we reported the accumulation of LDs in glia 
of the central nervous system of Vps13 mutant flies.  
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LDs were found in close association with the newly identified membrane structures in the Drosophila 
ovary (Chapter 5). It is known that LDs are important for formation of membrane structures, including 
autophagomes48,49. In addition, autophagosomes derive their membrane from multiple other organelles 
including ER and mitochondria and form at ER-mitochondria contact sites41,49,50. Together this might 
connect the presence of VPS13A at MCSs, the formation of a Vps13-dependent membrane structure 
during developmental PCD and the accumulation of LD in the absence of Vps13, although a role for Vps13 
in MCSs in Drosophila has not been shown.  
CRISPR/Cas9 as the technique of the future?
The CRISPR/Cas9 technique that we adapted (Chapter 4) approved to be of high value in our research and 
enabled us to study the localization of Drosophila Vps13 in a well-controlled manner. However, a critical 
note must be placed about the generation of off-target mutations when applying this technique. While 
generating the Vps13null mutant using CRISPR/Cas9 we observed multiple lines with various phenotypes 
that turned out to be unrelated to a mutation in Vps13. It is therefore of importance to be aware of the 
possibility that off-target mutations are created, even though multiple prediction programs might have 
predicted otherwise. In our study we thoroughly verified that the phenotypes we observed in our CRISPR/
Cas9 generated Vps13null mutant are due to the particular mutation in Vps13, rather than them being the 
consequence of an off-target event (Chapter 4). A very recent publication of Kosicki et al. (2018)51 reports 
that large deletions and other mutations can occur several kilobases from the target site, which can be 
missed when only a relatively small genomic region surrounding the target site is screened. It might have 
potential pathogenic consequences when those events take place in stem cells or progenitor cells and 
go unnoticed51. So although CRISPR/Cas9 has many benefits and might be very promising for future 
applications in health and disease, potential pitfalls of the technique should not be underestimated. 
Concluding remarks and future perspectives
The data presented in this thesis expands the body of knowledge about VPS13A function and localization 
by identifying its localization in both mammalian cells and a multicellular organism, all summarized 
in Figure 1. The versatility and dynamic localization define VPS13A as a so-called “Swiss army knife” [R. 
Fuller, Ann Arbor, Michigan, 2016], whereby its function depends on the cellular localization and binding 
partners. The VPS13 adaptor binding (VAB) domain identified in yeast is conserved in human VPS13A43 and 
Drosophila Vps13 (unpublished data). Mass Spectrometry analysis of human VPS13A and Drosophila Vps13 
will be of high value in identifying new adaptor proteins that interact with the VAB domain and thereby 
opening new roads for the investigation of VPS13A function. The Drosophila models that we generated 
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Figure 1. Overview of VPS13A localization and function identified in this thesis and by others.
Schematic representation of localization and functions of VPS13 that we identified in this thesis (dark purple), in addition to previously 
found localization and function of VPS13 (faint structures, light purple), which are discussed in Chapter 1. Drosophila Vps13 was found 
in close proximity to the plasma membrane and is involved in formation of a specialized membrane structure during developmental 
programmed cell death in oogenesis (1). Human VPS13A localizes to the ER-mitochondria interface (2) and translocates to LDs upon 
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